FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beal, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beal, M. F.

The FASEB Journal, Vol 6, 3338-3344, Copyright © 1992 by The Federation of American Societies for Experimental Biology


REVIEWS

Mechanisms of excitotoxicity in neurologic diseases

MF Beal
Neurochemistry Laboratory, Massachusetts General Hospital, Boston.

Excitotoxicity refers to neuronal cell death caused by activation of excitatory amino acid receptors. A substantial body of evidence has implicated excitotoxicity as a mechanism of cell death in both acute and chronic neurologic diseases. A major recent advance has been the successful cloning and expression of the N-methyl-D-aspartate (NMDA), non-NMDA, and metabotropic glutamate receptors. The cellular mechanisms responsible for cell death after activation of these receptors are still being clarified. In acute neurologic diseases such as stroke and head trauma, excitotoxicity may be related to excessive glutamate release. In chronic neurodegenerative diseases, however, a slow excitotoxic process is more likely to occur as a consequence of either a receptor abnormality or an impairment of energy metabolism. Recent therapeutic studies have demonstrated the efficacy of non-NMDA receptor antagonists in experimental studies of global ischemia.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
C. Wang and W. Slikker Jr
Strategies and Experimental Models for Evaluating Anesthetics: Effects on the Developing Nervous System
Anesth. Analg., June 1, 2008; 106(6): 1643 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Slikker Jr, X. Zou, C. E. Hotchkiss, R. L. Divine, N. Sadovova, N. C. Twaddle, D. R. Doerge, A. C. Scallet, T. A. Patterson, J. P. Hanig, et al.
Ketamine-Induced Neuronal Cell Death in the Perinatal Rhesus Monkey
Toxicol. Sci., July 1, 2007; 98(1): 145 - 158.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Wang, N. Sadovova, C. Hotchkiss, X. Fu, A. C. Scallet, T. A. Patterson, J. Hanig, M. G. Paule, and W. Slikker Jr.
Blockade of N-Methyl-D-Aspartate Receptors by Ketamine Produces Loss of Postnatal Day 3 Monkey Frontal Cortical Neurons in Culture
Toxicol. Sci., May 1, 2006; 91(1): 192 - 201.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Jacquard, Y. Trioulier, F. Cosker, C. Escartin, N. Bizat, P. Hantraye, J. M. Cancela, G. Bonvento, and E. Brouillet
Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation
FASEB J, May 1, 2006; 20(7): 1021 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. Lau, W. G. McLean, D. P. Williams, and C. V. Howard
Synergistic Interactions between Commonly Used Food Additives in a Developmental Neurotoxicity Test
Toxicol. Sci., March 1, 2006; 90(1): 178 - 187.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Pieri, C. Severini, G. Amadoro, I. Carunchio, C. Barbato, M. T. Ciotti, and C. Zona
AMPA Receptors Are Modulated by Tachykinins in Rat Cerebellum Neurons
J Neurophysiol, October 1, 2005; 94(4): 2484 - 2490.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. D. Marks, C. Boriboun, and J. Wang
Mitochondrial Nitric Oxide Mediates Decreased Vulnerability of Hippocampal Neurons from Immature Animals to NMDA
J. Neurosci., July 13, 2005; 25(28): 6561 - 6575.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Ferrani-Kile and S. W. Leslie
Modulation of Protein Tyrosine Phosphatase Activity Alters the Subunit Assembly in Native N-Methyl-D-aspartate Receptor Complex
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 86 - 93.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J.-C. Lievens, T. Rival, M. Iche, H. Chneiweiss, and S. Birman
Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila
Hum. Mol. Genet., March 1, 2005; 14(5): 713 - 724.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Hunot, M. Vila, P. Teismann, R. J. Davis, E. C. Hirsch, S. Przedborski, P. Rakic, and R. A. Flavell
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease
PNAS, January 13, 2004; 101(2): 665 - 670.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Wang, J. A. Kaufmann, M. G. Sanchez-Ross, and K. M. Johnson
Mechanisms of N-Methyl-D-aspartate-Induced Apoptosis in Phencyclidine-Treated Cultured Forebrain Neurons
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 287 - 295.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
N. G. Carlson, W. A. Wieggel, J. Chen, A. Bacchi, S. W. Rogers, and L. C. Gahring
Inflammatory Cytokines IL-1{alpha}, IL-1{beta}, IL-6, and TNF-{alpha} Impart Neuroprotection to an Excitotoxin Through Distinct Pathways
J. Immunol., October 1, 1999; 163(7): 3963 - 3968.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Delaney, P. N. Shepel, and J. D. Geiger
Levels of Endogenous Adenosine in Rat Striatum. I. Regulation by Ionotropic Glutamate Receptors, Nitric Oxide and Free Radicals
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 561 - 567.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G.-Q. Chen and E. Gouaux
Overexpression of a glutamate receptor (GluR2) ligand binding domain in Escherichia coli: Application of a novel protein folding screen
PNAS, December 9, 1997; 94(25): 13431 - 13436.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. Murai, H. Ishibashi, S. Koyama, and N. Akaike
Ca2+-Activated K+ Currents in Rat Locus Coeruleus Neurons Induced by Experimental Ischemia, Anoxia, and Hypoglycemia
J Neurophysiol, November 1, 1997; 78(5): 2674 - 2681.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Paquet, M. Tremblay, J.-J. Soghomonian, and Y. Smith
AMPA and NMDA Glutamate Receptor Subunits in Midbrain Dopaminergic Neurons in the Squirrel Monkey: An Immunohistochemical and In Situ Hybridization Study
J. Neurosci., February 15, 1997; 17(4): 1377 - 1396.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The Federation of American Societies for Experimental Biology.